Skip to main content
. 2022 Nov 23;12:1022496. doi: 10.3389/fonc.2022.1022496

Table 2.

Adverse events.

Event Overall (n = 9) Cohort 1 (n=4) Cohort 2 (n=5)
ALL Grades Grade ≥ 3 ALL Grades Grade ≥ 3 ALL Grades Grade ≥ 3
Any event 8 8 4 3 5 5
Dermatitis 8 7 3 2 5 5
Electrolyte abnormality 7 0 3 2 5 5
Arthralgias 7 2 2 1 5 1
Fatigue 6 0 4 0 2 0
Hepatitis 5 1 2 1 3 0
Fever 4 0 2 0 2 0
Diarrhea 4 2 2 1 2 1
Hypothyroidism 4 0 2 0 2 0
Anemia 4 0 4 0 0 0
Nausea 4 0 4 0 0 0
Burn 3 0 1 0 2 0
Neurotropenia 2 0 1 0 1 0
Thrombocytopenia 2 0 2 0 0 0
Mucositis 2 0 1 0 1 0
Atrial fibrillation 1 0 1 0 0 0
Hypertension 1 0 1 0 0 0
Soft tissue infection 1 0 1 0 0 0
Thrush 1 0 0 0 1 0
Pneumonitis 1 0 1 0 0 0
Adrenal Insufficiency 1 1 0 0 1 1
Edema 1 0 0 0 1 0